The board of directors of Tianjin TEDA Biomedical Engineering Company Limited announced that, based on a preliminary assessment on the existing unaudited management accounts and the information currently available, the Group is expected to record a significant increase in profit for the year ended 31 December 2015 as compared with that for the year ended 31 December 2014. The increase in profit is mainly attributable to the profit contributed by the active fertilizers and bio-organic fertilizers with higher gross profit margin which were launched into the market by the Group in 2015.
Tianjin TEDA Biomedical Engineering Company Limited
Equities
8189
CNE1000004H7
Agricultural Chemicals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.072 HKD | 0.00% | +1.41% | -19.10% |
1st Jan change | Capi. | |
---|---|---|
-19.10% | 17.47M | |
-14.47% | 15.05B | |
+0.50% | 11.85B | |
-14.33% | 9.84B | |
-.--% | 7.61B | |
-16.81% | 7.12B | |
+27.39% | 5.58B | |
-19.19% | 5.42B | |
+34.98% | 2.42B | |
+3.51% | 2.08B |
- Stock Market
- Equities
- 8189 Stock
- News Tianjin TEDA Biomedical Engineering Company Limited
- Tianjin TEDA Biomedical Engineering Company Limited Provides Earnings Guidance for the Year Ended December 31, 2015